NO954717L - Anti-kolesterolemi egg, vaksine, fremgangsmåte for fremstilling derav og anvendelse - Google Patents

Anti-kolesterolemi egg, vaksine, fremgangsmåte for fremstilling derav og anvendelse

Info

Publication number
NO954717L
NO954717L NO954717A NO954717A NO954717L NO 954717 L NO954717 L NO 954717L NO 954717 A NO954717 A NO 954717A NO 954717 A NO954717 A NO 954717A NO 954717 L NO954717 L NO 954717L
Authority
NO
Norway
Prior art keywords
eggs
warm
relates
bacterial antigens
hyperimmunized
Prior art date
Application number
NO954717A
Other languages
English (en)
Norwegian (no)
Other versions
NO954717D0 (no
Inventor
Ralph J Stolle
Lee R Beck
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22073631&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO954717(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Publication of NO954717D0 publication Critical patent/NO954717D0/no
Publication of NO954717L publication Critical patent/NO954717L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L15/00—Egg products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO954717A 1993-05-26 1995-11-22 Anti-kolesterolemi egg, vaksine, fremgangsmåte for fremstilling derav og anvendelse NO954717L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6708893A 1993-05-26 1993-05-26
PCT/US1993/005198 WO1994027623A1 (en) 1993-05-26 1993-05-28 Anti-cholesterolemic egg, vaccine and method for production, and use

Publications (2)

Publication Number Publication Date
NO954717D0 NO954717D0 (no) 1995-11-22
NO954717L true NO954717L (no) 1996-01-26

Family

ID=22073631

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954717A NO954717L (no) 1993-05-26 1995-11-22 Anti-kolesterolemi egg, vaksine, fremgangsmåte for fremstilling derav og anvendelse

Country Status (14)

Country Link
EP (1) EP0707485B1 (de)
JP (1) JPH09500870A (de)
AT (1) ATE216249T1 (de)
AU (1) AU690521B2 (de)
BR (1) BR9307851A (de)
CA (1) CA2163737A1 (de)
DE (1) DE69331836T2 (de)
DK (1) DK0707485T3 (de)
ES (1) ES2177546T3 (de)
FI (1) FI955692L (de)
IL (1) IL105845A0 (de)
NO (1) NO954717L (de)
NZ (1) NZ254326A (de)
WO (1) WO1994027623A1 (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357272A (en) * 1978-03-22 1982-11-02 The South African Inventions Development Corporation Recovering purified antibodies from egg yolk
JPS57144215A (en) * 1981-03-02 1982-09-06 Nippon Nousan Kogyo Kk Composition for improving lipometabolism
US5215746A (en) * 1982-06-03 1993-06-01 Stolle Research And Development Corporation Anti-cholesterolemic egg, vaccine and method for production, and use
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
JPH0651632B2 (ja) * 1985-09-05 1994-07-06 昭和産業株式会社 降コレステロ−ル剤

Also Published As

Publication number Publication date
WO1994027623A1 (en) 1994-12-08
FI955692A0 (fi) 1995-11-24
EP0707485A1 (de) 1996-04-24
NO954717D0 (no) 1995-11-22
DE69331836D1 (de) 2002-05-23
BR9307851A (pt) 1996-03-19
AU4597993A (en) 1994-12-20
EP0707485B1 (de) 2002-04-17
FI955692A7 (fi) 1996-01-24
AU690521B2 (en) 1998-04-30
IL105845A0 (en) 1993-12-28
JPH09500870A (ja) 1997-01-28
ES2177546T3 (es) 2002-12-16
DE69331836T2 (de) 2002-08-22
NZ254326A (en) 1998-01-26
FI955692L (fi) 1996-01-24
ATE216249T1 (de) 2002-05-15
CA2163737A1 (en) 1994-12-08
DK0707485T3 (da) 2002-08-26

Similar Documents

Publication Publication Date Title
KR20120061067A (ko) 병적 장애의 치료 및/또는 예방에 이용되는 항-ｌｐｓ 풍부한 면역글로블린 조제물
WO1993020843A1 (en) Oral treatment of helicobacter infection
US5753268A (en) Anti-cholesterolemic egg, vaccine and method for production, and use
DE3504221A1 (de) Verfahren zur passiven immunisierung von saeugern unter verwendung von antikoerpern von gefluegel und/oder boviden und antikoerpergemische
Wells et al. The increased severity of atherosclerosis in rabbits on a lactose-containing diet
US5215746A (en) Anti-cholesterolemic egg, vaccine and method for production, and use
US5853765A (en) Anti-cholesterolemic egg, vaccine and method for production, and use
Bayyari et al. Experimental reproduction of proventriculitis using homogenates of proventricuiar tissue
Hoshi et al. Comparison of adjuvants with respect to serum IgG antibody response in orally immunized chickens
US5849349A (en) Anti-cholesterolemic egg, vaccine and method for production, and use
NO954717D0 (no) Anti-kolesterolemi egg, vaksine, fremgangsmåte for fremstilling derav og anvendelse
DK0626008T3 (da) Vaccine, der som en adjuvans indeholder acemannan
KR100789488B1 (ko) 과면역 난 생성물 함유 조성물
JP2912451B2 (ja) ハチミツのワクチンとしての用途
JP2008169142A (ja) 食中毒菌に対する抗体の産生方法
Hanson et al. Anti-inflammatory capacities of human milk: lactoferrin and secretory IgA inhibit endotoxin-induced cytokine release
Vainio et al. Early ontogeny of germinal center formation in the chicken
DE19504755A1 (de) Aviäre, vitelline, gegen HIV-Antigene gerichtete Antikörper
CN109651489B (zh) 一种禽巴氏杆菌荚膜抗原a群卵黄抗体的制备方法
JP2003525868A (ja) 炎症を低減させるグルコサミンおよび卵
Mukkur et al. Possible immunological synergism among the protective antigens of Pasteurella multocida, type A
Ebrahimi et al. Evaluation of antibody levels during simultaneous aflatoxicosis and vaccination against infectious laryngotracheitis in pullets
Casswall Passive immunisation as therapy for gastrointestinal infections in children
RU97120744A (ru) Способ выращивания цыплят-бройлеров
Cohen et al. Immunity to parasitic infections